Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Total Current Liabilities (2016 - 2025)

China Pharma Holdings filings provide 16 years of Total Current Liabilities readings, the most recent being $7.4 million for Q4 2025.

  • On a quarterly basis, Total Current Liabilities rose 47.5% to $7.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.4 million, a 47.5% increase, with the full-year FY2025 number at $7.4 million, up 47.5% from a year prior.
  • Total Current Liabilities hit $7.4 million in Q4 2025 for China Pharma Holdings, up from $6.6 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $12.7 million in Q4 2022 to a low of $4.7 million in Q2 2024.
  • Median Total Current Liabilities over the past 5 years was $7.9 million (2022), compared with a mean of $8.4 million.
  • Biggest five-year swings in Total Current Liabilities: plummeted 55.32% in 2024 and later soared 47.5% in 2025.
  • China Pharma Holdings' Total Current Liabilities stood at $10.5 million in 2021, then increased by 21.17% to $12.7 million in 2022, then plummeted by 46.46% to $6.8 million in 2023, then fell by 26.44% to $5.0 million in 2024, then surged by 47.5% to $7.4 million in 2025.
  • The last three reported values for Total Current Liabilities were $7.4 million (Q4 2025), $6.6 million (Q3 2025), and $5.3 million (Q2 2025) per Business Quant data.